<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский физиологический журнал им. И.М. Сеченова</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-8139</issn><issn publication-format="electronic">2658-655X</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">691443</article-id><article-id pub-id-type="doi">10.7868/S2658655X25080041</article-id><article-id pub-id-type="edn">naejhj</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The Role of Dopamine in Chronic Pain: Neuroinflammation and Neurogenesis</article-title><trans-title-group xml:lang="ru"><trans-title>Роль дофамина при хронической боли: нейровоспаление и нейрогенез</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vetlugina</surname><given-names>A.</given-names></name><name xml:lang="ru"><surname>Ветлугина</surname><given-names>А.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fokeeva</surname><given-names>N. O.</given-names></name><name xml:lang="ru"><surname>Фокеева</surname><given-names>Н. О.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kochneva</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Кочнева</surname><given-names>А. А.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kalueff</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Калуев</surname><given-names>А. В.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Musienko</surname><given-names>P. E.</given-names></name><name xml:lang="ru"><surname>Мусиенко</surname><given-names>П. Е.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gerasimova</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Герасимова</surname><given-names>Е. В.</given-names></name></name-alternatives><email>gerasimova.el.2011@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Department of Neurobiology, Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology</institution></aff><aff><institution xml:lang="ru">Научный центр генетики и наук о жизни, направление “Нейробиология”, научно-технологический университет “Сириус”</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Translational Biomedicine, Saint Petersburg State University</institution></aff><aff><institution xml:lang="ru">Институт трансляционной биомедицины, Санкт-Петербургский государственный университет</institution></aff></aff-alternatives><aff id="aff3"><institution>Life Improvement by Future Technologies Center “LIFT”</institution></aff><aff-alternatives id="aff4"><aff><institution xml:lang="en">Federal Center of Brain Research and Neurotechnologies</institution></aff><aff><institution xml:lang="ru">Федеральный центр мозга и нейротехнологий</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-08-15" publication-format="electronic"><day>15</day><month>08</month><year>2025</year></pub-date><volume>111</volume><issue>8</issue><issue-title xml:lang="en">VOL 111, NO (2025)</issue-title><issue-title xml:lang="ru">ТОМ 111, № (2025)</issue-title><fpage>1296</fpage><lpage>1321</lpage><history><date date-type="received" iso-8601-date="2025-09-26"><day>26</day><month>09</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Российская академия наук</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-08-23"/></permissions><self-uri xlink:href="https://journals.eco-vector.com/0869-8139/article/view/691443">https://journals.eco-vector.com/0869-8139/article/view/691443</self-uri><abstract xml:lang="en"><p>Chronic pain is a complex condition that directly affects the quality of life of patients. Regulation and treatment of chronic pain are associated with a number of difficulties, primarily due to the multifactorial nature of this condition. The causes of chronic pain can be associated not only with physical damage, such as various injuries, diseases and the development of neuroinflammation, but also with a violation of the synthesis of neurotransmitters, as well as complex processes of neurogenesis. In this review, we describe the complex and multifaceted interaction between dopaminergic regulation, neurogenesis and neuroinflammation on the development of chronic pain. Further studies of these relationships can lead to the creation of targeted therapeutic strategies aimed at eliminating chronic pain. Moreover, understanding the mechanisms underlying analgesia associated with the dopamine reward system can form the basis for the development of new therapeutic approaches to relieve and control pain.</p></abstract><trans-abstract xml:lang="ru"><p>Хроническая боль представляет собой сложное заболевание, непосредственно влияющее на качество жизни пациентов. Ее регуляция и лечение связаны с рядом трудностей, в первую очередь из-за многофакторности этого состояния. Причины хронической боли могут быть связаны не только с физическими повреждениями, такими как различные травмы, заболевания и развитие нейровоспаления, но и с нарушением синтеза нейромедиаторов, а также сложных процессов нейрогенеза. В данном обзоре описано сложное и многогранное взаимодействие между такими факторами, как дофаминергическая регуляция, нейрогенез, нейровоспаление и их влияние на развитие хронической боли. Дальнейшие исследования этих взаимосвязей могут привести к созданию целенаправленных терапевтических стратегий, направленных на устранение хронической боли, а понимание механизмов, лежащих в основе анальгезии, связанной с дофаминовой системой вознаграждения, может способствовать разработке новых терапевтических подходов для облегчения и контроля боли.</p></trans-abstract><kwd-group xml:lang="en"><kwd>dopamine</kwd><kwd>neuroinflammation</kwd><kwd>neurogenesis</kwd><kwd>chronic pain</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>дофамин</kwd><kwd>нейровоспаление</kwd><kwd>нейрогенез</kwd><kwd>хроническая боль</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH, Raja SN (2017) Neuropathic pain. Nat Rev Dis Primer 3: 1–19. https://doi.org/10.1038/nrdp.2017.2</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Torrance N, Smith BH, Bennett MI, Lee AJ (2006) The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7: 281–289. https://doi.org/10.1016/j.jpain.2005.11.008</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Tesfaye S, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P (2010) Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments. Diabetes Care 33: 2285–2293. https://doi.org/10.2337/dc10-1303</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Johnson RW, Rice ASC (2014) Postherpetic Neuralgia. N Engl J Med 371: 1526–1533. https://doi.org/10.1056/NEJMcp1403062</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Siddall PJ, Loeser JD (2001) Pain following spinal cord injury. Spinal Cord 39: 63–73. https://doi.org/10.1038/sj.sc.3101116</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17: 113. https://doi.org/10.1111/j.1468-1331.2010.02999.x</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Baron R, Binder A, Wasner G (2010) Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9: 807–819. https://doi.org/10.1016/S1474-4422(10)70143-5</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 10: 287–287. https://doi.org/10.1016/j.ejpain.2005.06.009</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Akerman S, Goadsby P (2007) Dopamine and Migraine: Biology and Clinical Implications. Cephalalgia 27: 1308–1314. https://doi.org/10.1111/j.1468-2982.2007.01478.x</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ramachandran R (2018) Neurogenic inflammation and its role in migraine. Semin Immunopathol 40: 301–314. https://doi.org/10.1007/s00281-018-0676-y</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Cheyuo C, Aziz M, Wang P (2019) Neurogenesis in Neurodegenerative Diseases: Role of MFG-E8. Front Neurosci 13: 569. https://doi.org/10.3389/fnins.2019.00569</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Dreyer JK (2014) Three Mechanisms by which Striatal Denervation Causes Breakdown of Dopamine Signaling. J Neurosci 34: 12444–12456. https://doi.org/10.1523/JNEUROSCI.1458-14.2014</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Chakrabarti S, Bisaglia M (2023) Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products. Antioxidants 12: 955. https://doi.org/10.3390/antiox12040955</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hastings TG (2009) The role of dopamine oxidation in mitochondrial dysfunction: Implications for Parkinson’s disease. J Bioenerg Biomembr 41: 469–472. https://doi.org/10.1007/s10863-009-9257-z</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Wu Z, Ren Z, Gao R, Sun K, Sun F, Liu T, Zheng S, Wang W, Zhang G (2024) Impact of subthalamic nucleus deep brain stimulation at different frequencies on neurogenesis in a rat model of Parkinson’s disease. Heliyon 10. https://doi.org/10.1016/j.heliyon.2024.e30730</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Bao Y-N, Dai W-L, Fan J-F, Ma B, Li S-S, Zhao W-L, Yu B-Y, Liu J-H (2021) The dopamine D1–D2DR complex in the rat spinal cord promotes neuropathic pain by increasing neuronal excitability after chronic constriction injury. Exp Mol Med 53: 235–249. https://doi.org/10.1038/s12276-021-00563-5</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lai A, Iliff D, Zaheer K, Wang D, Gansau J, Laudier DM, Zachariou V, Iatridis JC (2023) Spinal Cord Sensitization and Spinal Inflammation from an In Vivo Rat Endplate Injury Associated with Painful Intervertebral Disc Degeneration. Int J Mol Sci 24: 3425. https://doi.org/10.3390/ijms24043425</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Rusanescu G (2016) Adult spinal cord neurogenesis: A regulator of nociception. Neurogenesis 3: e1256853. https://doi.org/10.1080/23262133.2016.1256853</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Almeida JGD, Kurita GP, Braga PE, Pimenta CADM (2010) Dor crônica em pacientes esquizofrênicos: prevalência e características. Cad Saúde Pública 26: 591–602. https://doi.org/10.1590/S0102-311X2010000300016</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Zhang Q (2024) Stress, Dopamine and the Development of Schizophrenia. Lect Notes Educ Psychol Public Media 33: 215–220. https://doi.org/10.54254/2753-7048/33/20231749</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Lurie DI (2018) An Integrative Approach to Neuroinflammation in Psychiatric disorders and Neuropathic Pain. J Exp Neurosci 12: 1179069518793639. https://doi.org/10.1177/1179069518793639</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Salter MW, Pitcher GM (2012) Dysregulated Src upregulation of NMDA receptor activity: A common link in chronic pain and schizophrenia. FEBS J 279: 2–11. https://doi.org/10.1111/j.1742-4658.2011.08390.x</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Bhatia A, Lenchner JR, Saadabadi A (2024) Biochemistry, Dopamine Receptors. In: StatPearls. StatPearls Publ. Treasure Island (FL).</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Navratilova E, Porreca F (2014) Reward and motivation in pain and pain relief. Nat Neurosci 17: 1304–1312. https://doi.org/10.1038/nn.3811</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Lee M, Manders TR, Eberle SE, Su C, D’amour J, Yang R, Lin HY, Deisseroth K, Froemke RC, Wang J (2015) Activation of corticostriatal circuitry relieves chronic neuropathic pain. J Neurosci Off J Soc Neurosci 35: 5247–5259. https://doi.org/10.1523/JNEUROSCI.3494-14.2015</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Geha PY, Baliki MN, Chialvo DR, Harden RN, Paice JA, Apkarian AV (2007) Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain 128: 88–100. https://doi.org/10.1016/j.pain.2006.09.014</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Desch S, Schweinhardt P, Seymour B, Flor H, Becker S (2023) Evidence for dopaminergic involvement in endogenous modulation of pain relief. Elife 1: 12e81436. https://elifesciences.org/articles/81436. Accessed 27 Sep 2024</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Romero TRL, Resende LC, Guzzo LS, Duarte IDG (2013) CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System. Anesth Analg 116: 463. https://doi.org/10.1213/ANE.0b013e3182707859</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>DosSantos MF, Holanda-Afonso RC, Lima RL, DaSilva AF, Moura-Neto V (2014) The role of the bloodâ€“brain barrier in the development and treatment of migraine and other pain disorders. Front Cell Neurosci 8. https://doi.org/10.3389/fncel.2014.00302</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Ji R-R, Nackley A, Huh Y, Terrando N, Maixner W (2018) Neuroinflammation and Central Sensitization in Chronic and Widespread Pain. Anesthesiology 129: 343–366. https://doi.org/10.1097/ALN.0000000000002130</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Matsuda M, Huh Y, Ji R-R (2019) Roles of Inflammation, Neurogenic inflammation, and Neuroinflammation in Pain. J Anesth 33: 131–139. https://doi.org/10.1007/s00540-018-2579-4</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413: 203–210. https://doi.org/10.1038/35093019</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Nikolenko VN, Shelomentseva EM, Tsvetkova MM, Abdeeva EI, Giller DB, Babayeva JV, Achkasov EE, Gavryushova LV, Sinelnikov MY (2022) Nociceptors: Their Role in Body’s Defenses, Tissue Specific Variations and Anatomical Update. J Pain Res 15: 867–877. https://doi.org/10.2147/JPR.S348324</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Puopolo M (2019) The hypothalamic-spinal dopaminergic system: A target for pain modulation. Neural Regen Res 14: 925. https://doi.org/10.4103/1673-5374.250567</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Bravo L, Llorca-Torralba M, Berrocoso E, Micó JA (2019) Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain. Front Neurosci 13: 1268. https://doi.org/10.3389/fnins.2019.01268</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Cohen SP, Vase L, Hooten WM (2021) Chronic pain: An update on burden, best practices, and new advances. The Lancet 397: 2082–2097. https://doi.org/10.1016/S0140-6736(21)00393-7</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Kaplan CM, Kelleher E, Irani A, Schrepf A, Clauw DJ, Harte SE (2024) Deciphering nociplastic pain: Clinical features, risk factors and potential mechanisms. Nat Rev Neurol 20: 347–363. https://doi.org/10.1038/s41582-024-00966-8</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Loeser JD, Treede R-D (2008) The Kyoto protocol of IASP Basic Pain Terminology. Pain 137: 473–477. https://doi.org/10.1016/j.pain.2008.04.025</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Bennett DLH (2001) Neurotrophic Factors: Important Regulators of Nociceptive Function. The Neuroscientist 7: 13–17. https://doi.org/10.1177/107385840100700105</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Sneddon LU (2018) Comparative Physiology of Nociception and Pain. Physiol Bethesda Md 33: 63–73. https://doi.org/10.1152/physiol.00022.2017</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Willis WD, Westlund KN (1997) Neuroanatomy of the Pain System and of the Pathways That Modulate Pain. J Clin Neurophysiol Off Publ Am Electroencephalogr Soc 14: 2–31. https://doi.org/10.1097/00004691-199701000-00002</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Wei S-Q, Tao Z-Y, Xue Y, Cao D-Y (2020) Peripheral Sensitization. In: Turker H, Garcia Benavides L, Ramos Gallardo G, Méndez Del Villar M (eds) Peripheral Nerve Disorders and Treatment. IntechOpen.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Yeh T-Y, Luo I-W, Hsieh Y-L, Tseng T-J, Chiang H, Hsieh S-T (2020) Peripheral Neuropathic Pain: From Experimental Models to Potential Therapeutic Targets in Dorsal Root Ganglion Neurons. Cells 9: 2725. https://doi.org/10.3390/cells9122725</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Hiraga S, Itokazu T, Nishibe M, Yamashita T (2022) Neuroplasticity related to chronic pain and its modulation by microglia. Inflamm Regen 42: 15. https://doi.org/10.1186/s41232-022-00199-6</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Garcia-Garrote M, Parga JA, Labandeira PJ, Labandeira-Garcia JL, Rodriguez-Pallares J (2021) Dopamine Regulates Adult Neurogenesis in the Ventricular-Subventricular Zone via Dopamine D3 Angiotensin Type 2 Receptor Interactions. Stem Cells 39: 1778–1794. https://doi.org/10.1002/stem.3457</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Aravagiri K, Ali A, Wang HC, Candido KD, Knezevic NN (2022) Identifying molecular mechanisms of acute to chronic pain transition and potential drug targets. Expert Opin Ther Targets 26: 801–810. https://doi.org/10.1080/14728222.2022.2137404</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>van den Hoogen NJ, Patijn J, Tibboel D, Joosten EA (2020) Repetitive noxious stimuli during early development affect acute and long-term mechanical sensitivity in rats. Pediatr Res 87: 26–31. https://doi.org/10.1038/s41390-019-0420-x</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Ott T, Nieder A (2019) Dopamine and Cognitive Control in Prefrontal Cortex. Trends Cogn Sci 23: 213–234. https://doi.org/10.1016/j.tics.2018.12.006</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Queiroz BFG, Fonseca FCS, Ferreira RCM, Romero TRL, Perez AC, Duarte IDG (2022) Analgesia and pain: Dual effect of dopamine on the peripheral nociceptive system is dependent on D2-or D1–like receptor activation. Eur J Pharmacol 922: 174872. https://doi.org/10.1016/j.ejphar.2022.174872</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Li C, Liu S, Lu X, Tao F (2019) Role of Descending Dopaminergic Pathways in Pain Modulation. Curr Neuropharmacol 17: 1176–1182. https://doi.org/10.2174/1570159X17666190430102531</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Almanza A, Simón-Arceo K, Coffeen U, Fuentes-García R, Contreras B, Pellicer F, Mercado F (2015) A D2-like receptor family agonist produces analgesia in mechanonociception but not in thermonociception at the spinal cord level in rats. Pharmacol Biochem Behav 137: 119–125. https://doi.org/10.1016/j.pbb.2015.08.013</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Liu S, Tang Y, Shu H, Tatum D, Bai Q, Crawford J, Xing Y, Lobo MK, Bellinger L, Kramer P, Tao F (2019) Dopamine receptor D2, but not D1, mediates descending dopaminergic pathway–produced analgesic effect in a trigeminal neuropathic pain mouse model. Pain 160: 334–344. https://doi.org/10.1097/j.pain.0000000000001414</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED (2012) Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain 153: 744–754. https://doi.org/10.1016/j.pain.2012.01.002</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Finan PH, Smith MT (2013) The comorbidity of insomnia, chronic pain, and depression: Dopamine as a putative mechanism. Sleep Med Rev 17: 173–183. https://doi.org/10.1016/j.smrv.2012.03.003</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Garcia Guerra S, Spadoni A, Mitchell J, Strigo IA (2023) Pain-related opioidergic and dopaminergic neurotransmission: Dual meta-Analyses of PET radioligand studies. Brain Res 1805: 148268. https://doi.org/10.1016/j.brainres.2023.148268</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Pan WHT, Yang S, Lin S (2004) Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse 53: 44–52. https://doi.org/10.1002/syn.20034</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Loomis CW, Jhamandas K, Milne B, Cervenko F (1987) Monoamine and opioid interactions in spinal analgesia and tolerance. Pharmacol Biochem Behav 26: 445–451. https://doi.org/10.1016/0091-3057(87)90146-8</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Wood PB (2008) Role of central dopamine in pain and analgesia. Expert Rev Neurother 8: 781–797. https://doi.org/10.1586/14737175.8.5.781</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Navratilova E, Xie JY, Okun A, Qu C, Eyde N, Ci S, Ossipov MH, King T, Fields HL, Porreca F (2012) Pain relief produces negative reinforcement through activation of mesolimbic reward–valuation circuitry. Proc Natl Acad Sci U S A109: 20709–20713. https://doi.org/10.1073/pnas.1214605109</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Navratilova E, Morimura K, Xie JY, Atcherley CW, Ossipov MH, Porreca F (2016) Positive emotions and brain reward circuits in chronic pain. J Comp Neurol 524: 1646–1652. https://doi.org/10.1002/cne.23968</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A (2004) Nitric Oxide as a Physiopathological Factor in Neuropsychiatric Disorders. In Vivo 18(3): 377–390.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Sokolov AY, Popova NS, Povarenkov AS, Amelin AV (2018) The role of dopamine in the mechanisms of primary headache formation. Neurochemistry 35: 323–337. https://doi.org/10.1134/S1027813318030147</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Gladstone J (2007) Dopamine and Migraine: Trigeminovascular Nociception, Genetics and Therapeutics. Cephalalgia 27: 1315–1320. https://doi.org/10.1111/j.1468-2982.2007.01479.x</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Marmura MJ (2012) Use of Dopamine Antagonists in Treatment of Migraine. Curr Treat Options Neurol 14: 27–35. https://doi.org/10.1007/s11940-011-0150-9</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Zhang W, Lei M, Wen Q, Zhang D, Qin G, Zhou J, Chen L (2022) Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine. J Headache Pain 23: 98. https://doi.org/10.1186/s10194-022-01469-x</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Mugnaini M, Trinchero MF, Schinder AF, Piatti VC, Kropff E (2023) Unique potential of immature adult-born neurons for the remodeling of CA3 spatial maps. 2022.09.14.507576</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Tan LL, Alfonso J, Monyer H, Kuner R (2021) Neurogenesis in the adult brain functionally contributes to the maintenance of chronic neuropathic pain. Sci Rep 11: 18549. https://doi.org/10.1038/s41598-021-97093-x</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Apkarian AV, Mutso AA, Centeno MV, Kan L, Wu M, Levinstein M, Banisadr G, Gobeske KT, Miller RJ, Radulovic J, Hen R, Kessler JA (2016) Role of adult hippocampal neurogenesis in persistent pain. Pain 157: 418–428. https://doi.org/10.1097/j.pain.0000000000000332</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Duric V, McCarson KE (2006) Persistent Pain Produces Stress-like Alterations in Hippocampal Neurogenesis and Gene Expression. J Pain 7: 544–555. https://doi.org/10.1016/j.jpain.2006.01.458</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Timmerman R, Burm SM, Bajramovic JJ (2018) An Overview of in vitro Methods to Study Microglia. Front Cell Neurosci 12. https://doi.org/10.3389/fncel.2018.00242</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Mecha M, Carrillo-Salinas FJ, Feliú A, Mestre L, Guaza C (2016) Microglia activation states and cannabinoid system: Therapeutic implications. Pharmacol Ther 166: 40–55. https://doi.org/10.1016/j.pharmthera.2016.06.011</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Wendimu MY, Hooks SB (2022) Microglia Phenotypes in Aging and Neurodegenerative Diseases. Cells 11: 2091. https://doi.org/10.3390/cells11132091</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Loane DJ, Byrnes KR (2010) Role of Microglia in Neurotrauma. Neurotherapeutics 7: 366–377. https://doi.org/10.1016/j.nurt.2010.07.002</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Kofler J, Wiley CA (2011) Microglia: Key Innate Immune Cells of the Brain. Toxicol Pathol 39: 103–114. https://doi.org/10.1177/0192623310387619</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Tang Y, Le W (2016) Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol 53: 1181–1194. https://doi.org/10.1007/s12035-014-9070-5</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Giovannoni F, Quintana FJ (2020) The Role of Astrocytes in CNS Inflammation. Trends Immunol 41: 805–819. https://doi.org/10.1016/j.it.2020.07.007</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Sofroniew MV (2015) Astrogliosis. Cold Spring Harb Perspect Biol 7: a020420. https://doi.org/10.1101/cshperspect.a020420</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Linnerbauer M, Wheeler MA, Quintana FJ (2020) Astrocyte Crosstalk in CNS Inflammation. Neuron 108: 608–622. https://doi.org/10.1016/j.neuron.2020.08.012</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Giovannoni F, Quintana FJ (2020) The role of astrocytes in CNS inflammation. Trends Immunol 41: 805–819.</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Abd-Ellatief RB, Mohamed HK, Kotb HI (2018) Reactive Astrogliosis in an Experimental Model of Fibromyalgia: Effect of Dexmedetomidine. Cells Tissues Organs 205: 105–119. https://doi.org/10.1159/000488757</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Prokhorenko MA, Smyth JT (2023) Astrocyte store-operated calcium entry is required for centrally mediated neuropathic pain. bioRxiv 2023.06.08.544231. https://doi.org/10.1101/2023.06.08.544231</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Lee JY, Park CS, Seo KJ, Kim IY, Han S, Youn I, Yune TY (2023) IL-6/JAK2/STAT3 axis mediates neuropathic pain by regulating astrocyte and microglia activation after spinal cord injury. Exp Neurol 370: 114576. https://doi.org/10.1016/j.expneurol.2023.114576</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Zhang R, Xu B, Zhang N, Niu J, Zhang M, Zhang Q, Chen D, Shi Y, Chen D, Liu K, Zhang X, Li N, Fang Q (2022) Spinal microglia-derived TNF promotes the astrocytic JNK/CXCL1 pathway activation in a mouse model of burn pain. Brain Behav Immun 102: 23–39. https://doi.org/10.1016/j.bbi.2022.02.006</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Hald A, Nedergaard S, Hansen RR, Ding M, Heegaard A-M (2009) Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain. Eur J Pain Lond Engl 13: 138–145. https://doi.org/10.1016/j.ejpain.2008.03.014</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Ben Haim L, Carrillo-de Sauvage M-A, CeyzÃ©riat K, Escartin C (2015) Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci 9. https://doi.org/10.3389/fncel.2015.00278</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Andersen JV, Schousboe A (2023) Milestone Review: Metabolic dynamics of glutamate and GABA mediated neurotransmission – The essential roles of astrocytes. J Neurochem 166: 109–137. https://doi.org/10.1111/jnc.15811</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Kriegstein A, Alvarez-Buylla A (2009) The Glial Nature of Embryonic and Adult Neural Stem Cells. Annu Rev Neurosci 32: 149–184. https://doi.org/10.1146/annurev.neuro.051508.135600</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Fölsz O, Trouche S, Croset V (2023) Adult-born neurons add flexibility to hippocampal memories. Front Neurosci 17. https://doi.org/10.3389/fnins.2023.1128623</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Rodríguez-Barrera R, Rivas-González M, García-Sánchez J, Mojica-Torres D, Ibarra A (2021) Neurogenesis after Spinal Cord Injury: State of the Art. Cells 10: 1499. https://doi.org/10.3390/cells10061499</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Shechter R, Baruch K, Schwartz M, Rolls A (2011) Touch gives new life: Mechanosensation modulates spinal cord adult neurogenesis. Mol Psychiatry 16: 342–352. https://doi.org/10.1038/mp.2010.116</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Katolikova NV, Khudiakov AA, Shafranskaya DD, Prjibelski AD, Masharskiy AE, Mor MS, Golovkin AS, Zaytseva AK, Neganova IE, Efimova EV, Gainetdinov RR, Malashicheva AB (2023) Modulation of Notch Signaling at Early Stages of Differentiation of Human Induced Pluripotent Stem Cells to Dopaminergic Neurons. Int J Mol Sci 24: 1429. https://doi.org/10.3390/ijms24021429</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Garcia-Garrote M, Parga JA, Labandeira PJ, Labandeira-Garcia JL, Rodriguez-Pallares J (2021) Dopamine Regulates Adult Neurogenesis in the Ventricular-Subventricular Zone via Dopamine D3 Angiotensin Type 2 Receptor Interactions. Stem Cells 39: 1778–1794. https://doi.org/10.1002/stem.3457</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Yu H, Yang S, Li H, Wu R, Lai B, Zheng Q (2023) Activating Endogenous Neurogenesis for Spinal Cord Injury Repair: Recent Advances and Future Prospects. Neurospine 20: 164–180. https://doi.org/10.14245/ns.2245184.296</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Zhang Y, Zhao D, Li X, Gao B, Sun C, Zhou S, Ma Y, Chen X, Xu D (2021) The Wnt/β-Catenin Pathway Regulated Cytokines for Pathological Neuropathic Pain in Chronic Compression of Dorsal Root Ganglion Model. Neural Plast 2021: 1–10. https://doi.org/10.1155/2021/6680192</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Garcia-Garrote M, Parga JA, Labandeira PJ, Labandeira-Garcia JL, Rodriguez-Pallares J (2021) Dopamine regulates adult neurogenesis in the ventricular-subventricular zone via dopamine D3 angiotensin type 2 receptor interactions. Stem Cells Dayt Ohio 39: 1778–1794. https://doi.org/10.1002/stem.3457</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Tail M, Zhang H, Zheng G, Hatami M, Skutella T, Unterberg A, Zweckberger K, Younsi A (2022) The Sonic Hedgehog Pathway Modulates Survival, Proliferation, and Differentiation of Neural Progenitor Cells under Inflammatory Stress In Vitro. Cells 11: 736. https://doi.org/10.3390/cells11040736</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation>Ding S, Yang J, Huang X, Liu L, Hu J, Xu Z, Zhuge Q (2017) Dopamine Burden Induced the Inactivation of Sonic Hedgehog Signaling to Cognitive Decline in Minimal Hepatic Encephalopathy. Aging Dis 8: 442. https://doi.org/10.14336/AD.2016.1123</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation>Iftikhar K, Niaz M, Shahid M, Zehra S, Afzal T, Faizi S, Simjee SU (2024) Hippocampal neurogenesis modulated by Quinic acid: A therapeutic strategy for the neurodegenerative disorders. Hippocampus 34: 540–550. https://doi.org/10.1002/hipo.23630</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Stockman SL, Kight KE, Bowers JM, McCarthy MM (2022) Neurogenesis in the neonatal rat hippocampus is regulated by sexually dimorphic epigenetic modifiers. Biol Sex Differ 13: 9. https://doi.org/10.1186/s13293-022-00418-2</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Hosseini SM, Alizadeh A, Shahsavani N, Chopek J, Ahlfors J-E, Karimi-Abdolrezaee S (2022) Suppressing CSPG/LAR/PTPσ Axis Facilitates Neuronal Replacement and Synaptogenesis by Human Neural Precursor Grafts and Improves Recovery after Spinal Cord Injury. J Neurosci 42: 3096–3121. https://doi.org/10.1523/JNEUROSCI.2177-21.2022</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Heinrich PC, Bode J, Decker M, Graeve L, Martens A, Müller-Newen G, Pflanz S, Schaper F, Schmitz J (2001) Termination and modulation of IL-6-type cytokine signaling. In: Mackiewicz A, Kurpisz M, Żeromski J (eds) Progress in Basic and Clinical Immunology. Springer US. Boston. MA. 153–160.</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation>Fölsz O, Trouche S, Croset V (2023) Adult-born neurons add flexibility to hippocampal memories. Front Neurosci 17: 1128623. https://doi.org/10.3389/fnins.2023.1128623</mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation>Gomes-Leal W (2021) Adult Hippocampal Neurogenesis and Affective Disorders: New Neurons for Psychic Well-Being. Front Neurosci 15: 594448. https://doi.org/10.3389/fnins.2021.594448</mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation>Kempermann G (2022) What Is Adult Hippocampal Neurogenesis Good for? Front Neurosci 16: 852680. https://doi.org/10.3389/fnins.2022.852680</mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation>Li H, Tamura R, Hayashi D, Asai H, Koga J, Ando S, Yokota S, Kaneko J, Sakurai K, Sumiyoshi A, Yamamoto T, Hikishima K, Tanaka KZ, McHugh TJ, Hisatsune T (2023) Dentate Neurogenesis Modulates Dorsal Hippocampal Excitation/Inhibition Balance Crucial for Cognitive Flexibility. bioRxiv 2023.02.22.529526. https://doi.org/10.1101/2023.02.22.529526</mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation>Mills EP, Keay KA, Henderson LA (2021) Brainstem Pain-Modulation Circuitry and Its Plasticity in Neuropathic Pain: Insights From Human Brain Imaging Investigations. Front Pain Res 2: 705345. https://doi.org/10.3389/fpain.2021.705345</mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation>Zhao Y, Zhang L, Wang M, Yu J, Yang J, Liu A, Yao H, Liu X, Shen Y, Guo B, Wang Y, Wu S (2018) Anxiety Specific Response and Contribution of Active Hippocampal Neural Stem Cells to Chronic Pain Through Wnt/β-Catenin Signaling in Mice. Front Mol Neurosci 11: 296. https://doi.org/10.3389/fnmol.2018.00296</mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation>Egorova E, Starinets A, Tyrtyshnaia A, Ponomarenko A, Manzhulo I (2019) Hippocampal Neurogenesis in Conditions of Chronic Stress Induced by Sciatic Nerve Injury in the Rat. Cells Tissues Organs 207: 58–68. https://doi.org/10.1159/000501236</mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation>Tyrtyshnaia A, Manzhulo I, Kipryushina Y, Ermolenko E (2019) Neuroinflammation and adult hippocampal neurogenesis in neuropathic pain and alkyl glycerol ethers treatment in aged mice. Int J Mol Med 43(5): 2153–2163. https://doi.org/10.3892/ijmm.2019.4142</mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation>Xie W-S, Shehzadi K, Ma H-L, Liang J-H (2022) A Potential Strategy for Treatment of Neurodegenerative Disordersby Regulation of Adult Hippocampal Neurogenesis in Human Brain. Curr Med Chem 29: 5315–5347. https://doi.org/10.2174/0929867329666220509114232</mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation>Gould E, Tanapat P (1999) Stress and hippocampal neurogenesis. Biol Psychiatry 46: 1472–1479. https://doi.org/10.1016/s0006-3223(99)00247-4</mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation>Levin OS, Artemiev DV, Brill EV, Kulua TK (2017). Parkinson's disease: Modern approaches to diagnosis and treatment. Pract Med 1(1(102)): 45–51. https://cyberleninka.ru/article/n/bolezn-parkinsona-sovremennye-podhody-k-diagnostike-i-lecheniyu</mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation>Grace PM, Hutchinson MR, Maier SF, Watkins LR (2014) Pathological pain and the neuroimmune interface. Nat Rev Immunol 14: 217–231. https://doi.org/10.1038/nri3621</mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation>Felger JC, Miller AH (2012) Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise. Front Neuroendocrinol 33: 315–327. https://doi.org/10.1016/j.yfrne.2012.09.003</mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation>Dong X-W, Jia Y, Lu SX, Zhou X, Cohen-Williams M, Hodgson R, Li H, Priestley T (2007) The antipsychotic drug, fluphenazine, effectively reverses mechanical allodynia in rat models of neuropathic pain. Psychopharmacology (Berl) 195: 559–568. https://doi.org/10.1007/s00213-007-0942-5</mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation>Qiao Y, Brodnik ZD, Zhao S, Trueblood CT, Li Z, Tom VJ, España RA, Hou S (2021) Spinal Dopaminergic Mechanisms Regulating the Micturition Reflex in Male Rats with Complete Spinal Cord Injury. J Neurotrauma 38: 803–817. https://doi.org/10.1089/neu.2020.7284</mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation>Zhu Y, Webster MJ, Mendez Victoriano G, Middleton FA, Massa PT, Weickert CS (2024) Molecular Evidence for Altered Angiogenesis in Neuroinflammation-Associated Schizophrenia and Bipolar Disorder Implicate an Abnormal Midbrain Blood-Brain Barrier. Schizophr Bull sbae184. https://doi.org/10.1093/schbul/sbae184</mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation>Debs SR, Rothmond DA, Zhu Y, Weickert CS, Purves-Tyson TD (2024) Molecular evidence of altered stress responsivity related to neuroinflammation in the schizophrenia midbrain. J Psychiatr Res 177: 118–128. https://doi.org/10.1016/j.jpsychires.2024.07.004</mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation>Xue S, Cao Z, Wang J, Zhao Q, Han J, Yang W, Sun T (2022) Receptor-Interacting Protein Kinase 3 Inhibition Relieves Mechanical Allodynia and Suppresses NLRP3 Inflammasome and NF-κB in a Rat Model of Spinal Cord Injury. Front Mol Neurosci 15: 861312. https://doi.org/10.3389/fnmol.2022.861312</mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation>Jiang W, Huang Y, He F, Liu J, Li M, Sun T, Ren W, Hou J, Zhu L (2016) Dopamine D1 Receptor Agonist A-68930 Inhibits NLRP3 Inflammasome Activation, Controls Inflammation, and Alleviates Histopathology in a Rat Model of Spinal Cord Injury: SPINE 41: E330–E334. https://doi.org/10.1097/BRS.0000000000001287</mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation>Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302: 1760–1765. https://doi.org/10.1126/science.1088417</mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation>Vallières L, Campbell IL, Gage FH, Sawchenko PE (2002) Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci Off J Soc Neurosci 22: 486–492. https://doi.org/10.1523/JNEUROSCI.22-02-00486.2002</mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation>Iosif RE, Ekdahl CT, Ahlenius H, Pronk CJH, Bonde S, Kokaia Z, Jacobsen S-EW, Lindvall O (2006) Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci Off J Soc Neurosci 26: 9703–9712. https://doi.org/10.1523/JNEUROSCI.2723-06.2006</mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation>Whitney NP, Eidem TM, Peng H, Huang Y, Zheng JC (2009) Inflammation mediates varying effects in neurogenesis: Relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem 108: 1343–1359. https://doi.org/10.1111/j.1471-4159.2009.05886.x</mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation>Ekdahl CT, Claasen J-H, Bonde S, Kokaia Z, Lindvall O (2003) Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A 100: 13632–13637. https://doi.org/10.1073/pnas.2234031100</mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation>Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S, Martino G, Schwartz M (2006) Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 31: 149–160. https://doi.org/10.1016/j.mcn.2005.10.006</mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation>Gao M, Dong Q, Zou D, Yang Z, Guo L, Chen Z, Xu R (2025) Induced neural stem cells regulate microglial activation through Akt-mediated upregulation of CXCR4 and Crry in a mouse model of closed head injury. Neural Regen Res 20(5): 1416-1430. 10.4103/NRR.NRR-D-23-01495</mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation>Bylicky MA, Mueller GP, Day RM (2018) Mechanisms of Endogenous Neuroprotective Effects of Astrocytes in Brain Injury. Oxid Med Cell Longev 2018: 6501031. https://doi.org/10.1155/2018/6501031</mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation>Körtési T, Nagy-Grócz G, Vécsei L (2024) The role of kynurenines in migraine-related neuroimmune pathways. J Headache Pain 25: 129. https://doi.org/10.1186/s10194-024-01833-z</mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation>Miguel-Hidalgo JJ, Pang Y (2021) Role of Neuroinflammation in the Establishment of the Neurogenic Microenvironment in Brain Diseases. Curr Tissue Microenviron Rep 2: 17–28. https://doi.org/10.1007/s43152-021-00028-x</mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation>North HF, Weissleder C, Bitar M, Barry G, Fullerton JM, Webster MJ, Weickert CS (2024) RNA-sequencing suggests extracellular matrix and vasculature dysregulation could impair neurogenesis in schizophrenia cases with elevated inflammation. Schizophrenia 10: 50. https://doi.org/10.1038/s41537-024-00466-0</mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation>Inta D, Meyer-Lindenberg A, Gass P (2011) Alterations in Postnatal Neurogenesis and Dopamine Dysregulation in Schizophrenia: A Hypothesis. Schizophr Bull 37: 674–680. https://doi.org/10.1093/schbul/sbq134</mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation>Rusanescu G (2016) Adult spinal cord neurogenesis: A regulator of nociception. Neurogenesis 3: e1256853. https://doi.org/10.1080/23262133.2016.1256853</mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation>Zeilhofer HU (2011) Spinal neuroplasticity in chronic pain. E-Neuroforum 17: 35–41. https://doi.org/10.1007/s13295-011-0018-1</mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation>Ohira K (2020) Dopamine as a growth differentiation factor in the mammalian brain. Neural Regen Res 15: 390. https://doi.org/10.4103/1673-5374.266052</mixed-citation></ref></ref-list></back></article>
